TreeWAS – Variant ID: rs9980603

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.041	0.959	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.032	0.968	0.000
C82.0 Small cleaved cell, follicular	0.029	0.971	0.000
C82.2 Large cell, follicular	0.027	0.973	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.025	0.975	0.000
C82.4 Follicular lymphoma grade IIIb	0.025	0.975	0.000
C82.3 Follicular lymphoma grade IIIa	0.025	0.975	0.000
C82.6 Cutaneous follicle centre lymphoma	0.023	0.976	0.000
C82.5 Diffuse follicle centre lymphoma	0.023	0.976	0.000
T39.0 Salicylates	0.018	0.982	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.017	0.982	0.000
T40.6 Other and unspecified narcotics	0.016	0.984	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.013	0.987	0.000
T40.4 Other synthetic narcotics	0.012	0.988	0.000
L89.1 Stage II decubitus ulcer	0.011	0.989	0.000
N19 Unspecified renal failure	0.000	0.989	0.011
T40.1 Heroin	0.011	0.989	0.000
T40.5 Cocaine	0.010	0.990	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.009	0.990	0.000
T40.8 Lysergide [LSD]	0.009	0.990	0.000
T40.7 Cannabis (derivatives)	0.009	0.990	0.000
T40.3 Methadone	0.009	0.990	0.000
T40.0 Opium	0.009	0.990	0.000
H73.8 Other specified disorders of tympanic membrane	0.009	0.991	0.000
K72.9 Hepatic failure, unspecified	0.008	0.992	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.008	0.992	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.008	0.992	0.000
I47.1 Supraventricular tachycardia	0.007	0.993	0.000
T40.2 Other opioids	0.007	0.993	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.007	0.993	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.007	0.993	0.000
T36 Poisoning by systemic antibiotics	0.007	0.993	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.000	0.993	0.006
T46.4 Angiotensin-converting-enzyme inhibitors	0.006	0.994	0.000
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.006	0.994	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.006	0.994	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.006	0.994	0.000
T36.0 Penicillins	0.006	0.994	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.006	0.994	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.006	0.994	0.000
T39.4 Antirheumatics, not elsewhere classified	0.006	0.994	0.000
T39.2 Pyrazolone derivatives	0.006	0.994	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
Z33 Pregnant state, incidental	0.006	0.994	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.006	0.994	0.000
T50.4 Drugs affecting uric acid metabolism	0.006	0.994	0.000
Q60.0 Renal agenesis, unilateral	0.000	0.994	0.006
C84 Peripheral and cutaneous T-cell lymphomas	0.006	0.994	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.006	0.994	0.000
T50.1 Loop [high-ceiling] diuretics	0.005	0.994	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.994	0.000
M22.2 Patellofemoral disorders	0.000	0.994	0.006
T41 Poisoning by anaesthetics and therapeutic gases	0.005	0.994	0.000
T50.7 Analeptics and opioid receptor antagonists	0.005	0.995	0.000
T50.5 Appetite depressants	0.005	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.995	0.000
C88 Malignant immunoproliferative diseases	0.005	0.995	0.000
T50.8 Diagnostic agents	0.005	0.995	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.005	0.995	0.000
H73 Other disorders of tympanic membrane	0.005	0.995	0.000
C91 Lymphoid leukaemia	0.005	0.995	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.005	0.995	0.000
L89 Decubitus ulcer	0.005	0.995	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.000	0.995	0.005
C84.4 Peripheral T-cell lymphoma	0.005	0.995	0.000
C95 Leukaemia of unspecified cell type	0.005	0.995	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.005	0.995	0.000
T36.9 Systemic antibiotic, unspecified	0.005	0.995	0.000
T36.8 Other systemic antibiotics	0.005	0.995	0.000
T36.7 Antifungal antibiotics, systemically used	0.005	0.995	0.000
T36.6 Rifamycins	0.005	0.995	0.000
T36.5 Aminoglycosides	0.005	0.995	0.000
T36.4 Tetracyclines	0.005	0.995	0.000
T36.3 Macrolides	0.005	0.995	0.000
T36.2 Chloramphenicol group	0.005	0.995	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.005	0.995	0.000
C94 Other leukaemias of specified cell type	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.005	0.995	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
C91.0 Acute lymphoblastic leukaemia	0.005	0.995	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.005	0.995	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.000	0.995	0.005
T46.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
T46.7 Peripheral vasodilators	0.005	0.995	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.005	0.995	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.005	0.995	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.005	0.995	0.000
C91.9 Lymphoid leukaemia, unspecified	0.005	0.995	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.005	0.995	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.005	0.995	0.000
Q63 Other congenital malformations of kidney	0.000	0.995	0.005
C93 Monocytic leukaemia	0.005	0.995	0.000
Q60-Q64 Congenital malformations of the urinary system	0.000	0.995	0.005
C84.0 Mycosis fungoides	0.005	0.995	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.005	0.995	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.004	0.995	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.005	0.995	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.995	0.000
M13.97 Arthritis, unspecified (Ankle and foot)	0.000	0.996	0.004
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.004	0.996	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.004	0.996	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.004	0.996	0.000
C84.3 Lymphoepithelioid lymphoma	0.004	0.996	0.000
C84.2 T-zone lymphoma	0.004	0.996	0.000
C84.1 Sezary's diease	0.004	0.996	0.000
C95.9 Leukaemia, unspecified	0.004	0.996	0.000
Q63.0 Accessory kidney	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
C86 Other specified types of T/NK-cell lymphoma	0.004	0.996	0.000
Q63.2 Ectopic kidney	0.000	0.996	0.004
C90.1 Plasma cell leukaemia	0.004	0.996	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
T44.0 Anticholinesterase agents	0.004	0.996	0.000
Q64 Other congenital malformations of urinary system	0.000	0.996	0.004
H73.1 Chronic myringitis	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
C90.0 Multiple myeloma	0.004	0.996	0.000
D32.9 Meninges, unspecified	0.000	0.996	0.004
O80.0 Spontaneous vertex delivery	0.000	0.996	0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
T48.4 Expectorants	0.004	0.996	0.000
T48.3 Antitussives	0.004	0.996	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
T48.0 Oxytocic drugs	0.004	0.996	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.004	0.996	0.000
T41.5 Therapeutic gases	0.004	0.996	0.000
T41.4 Anaesthetic, unspecified	0.004	0.996	0.000
T41.3 Local anaesthetics	0.004	0.996	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.996	0.000
T41.1 Intravenous anaesthetics	0.004	0.996	0.000
T41.0 Inhaled anaesthetics	0.004	0.996	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.004	0.996	0.000
C88.7 Other malignant immunoproliferative diseases	0.004	0.996	0.000
C88.3 Immunoproliferative small intestinal disease	0.004	0.996	0.000
C88.2 Gamma heavy chain disease	0.004	0.996	0.000
C88.1 Alpha heavy chain disease	0.004	0.996	0.000
T49.9 Topical agent, unspecified	0.004	0.996	0.000
T49.8 Other topical agents	0.004	0.996	0.000
T49.7 Dental drugs, topically applied	0.004	0.996	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.996	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.996	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.996	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.996	0.000
T49.2 Local astringents and local detergents	0.004	0.996	0.000
T49.1 Antipruritics	0.004	0.996	0.000
C94.4 Acute panmyelosis	0.004	0.996	0.000
H73.0 Acute myringitis	0.004	0.996	0.000
T48.5 Anti-common-cold drugs	0.004	0.996	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.004	0.996	0.000
C91.7 Other lymphoid leukaemia	0.004	0.996	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.004	0.996	0.000
C91.3 Prolymphocytic leukaemia	0.004	0.996	0.000
C91.2 Subacute lymphocytic leukaemia	0.004	0.996	0.000
C84.5 Other and unspecified T-cell lymphomas	0.004	0.996	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.004	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.004	0.996	0.000
T38.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
T38.7 Androgens and anabolic congeners	0.004	0.996	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.004	0.996	0.000
T38.5 Other oestrogens and progestogens	0.004	0.996	0.000
T38.4 Oral contraceptives	0.004	0.996	0.000
T38.2 Antithyroid drugs	0.004	0.996	0.000
T38.0 Glucocorticoids and synthetic analogues	0.004	0.996	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.000	0.996	0.004
Q60.6 Potter's syndrome	0.000	0.996	0.004
Q60.5 Renal hypoplasia, unspecified	0.000	0.996	0.004
Q60.4 Renal hypoplasia, bilateral	0.000	0.996	0.004
Q60.3 Renal hypoplasia, unilateral	0.000	0.996	0.004
Q60.1 Renal agenesis, bilateral	0.000	0.996	0.004
C95.7 Other leukaemia of unspecified cell type	0.004	0.996	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.004	0.996	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.000	0.996	0.004
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
C94.7 Other specified leukaemias	0.004	0.996	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.004	0.996	0.000
C94.5 Acute myelofibrosis	0.004	0.996	0.000
C94.3 Mast cell leukaemia	0.004	0.996	0.000
C94.2 Acute megakaryoblastic leukaemia	0.004	0.996	0.000
C94.1 Chronic erythraemia	0.004	0.996	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.004	0.996	0.000
C91.4 Hairy-cell leukaemia	0.004	0.996	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
T37.5 Antiviral drugs	0.004	0.996	0.000
T37.4 Anthelminthics	0.004	0.996	0.000
T37.3 Other antiprotozoal drugs	0.004	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
T37.1 Antimycobacterial drugs	0.004	0.996	0.000
T37.0 Sulphonamides	0.004	0.996	0.000
Q63.8 Other specified congenital malformations of kidney	0.000	0.996	0.004
Q60.2 Renal agenesis, unspecified	0.000	0.996	0.004
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.000	0.996	0.004
Q50.3 Other congenital malformations of ovary	0.000	0.996	0.004
Q50.2 Congenital torsion of ovary	0.000	0.996	0.004
Q50.1 Developmental ovarian cyst	0.000	0.996	0.004
Q50.0 Congenital absence of ovary	0.000	0.996	0.004
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.996	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.996	0.000
C96.8 Histiocytic sarcoma	0.003	0.996	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.996	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.003	0.996	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.003	0.996	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.003	0.996	0.000
C96.3 True histiocytic lymphoma	0.003	0.996	0.000
C96.2 Malignant mast cell tumour	0.003	0.996	0.000
C96.1 Malignant histiocytosis	0.003	0.996	0.000
C96.0 Letterer-Siwe disease	0.003	0.996	0.000
Q50.5 Embryonic cyst of broad ligament	0.000	0.996	0.004
Q63.9 Congenital malformation of kidney, unspecified	0.000	0.996	0.004
Q63.3 Hyperplastic and giant kidney	0.000	0.996	0.004
C93.9 Monocytic leukaemia, unspecified	0.003	0.996	0.000
C93.7 Other monocytic leukaemia	0.003	0.996	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.003	0.996	0.000
C93.2 Subacute monocytic leukaemia	0.003	0.996	0.000
C93.0 Acute monocytic leukaemia	0.003	0.996	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.996	0.000
T47.7 Emetics	0.003	0.996	0.000
T47.5 Digestants	0.003	0.996	0.000
T47.3 Saline and osmotic laxatives	0.003	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.996	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.996	0.000
Q50-Q56 Congenital malformations of genital organs	0.000	0.996	0.004
C93.1 Chronic monocytic leukaemia	0.003	0.996	0.000
Q64.7 Other congenital malformations of bladder and urethra	0.000	0.996	0.003
C92 Myeloid leukaemia	0.004	0.996	0.000
C90.3 Solitary plasmacytoma	0.003	0.996	0.000
T47.4 Other laxatives	0.003	0.996	0.000
T47.2 Stimulant laxatives	0.003	0.996	0.000
Q62.5 Duplication of ureter	0.000	0.997	0.003
L89.3 Stage IV decubitus ulcer	0.003	0.997	0.000
C91.5 Adult T-cell leukaemia	0.003	0.997	0.000
C91.1 Chronic lymphocytic leukaemia	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.003	0.997	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.003	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.003	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.003	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.003	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.003	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.003	0.997	0.000
I08.8 Other multiple valve diseases	0.003	0.997	0.000
C95.0 Acute leukaemia of unspecified cell type	0.003	0.997	0.000
S42.00 Fracture of clavicle (closed)	0.000	0.997	0.003
Q64.9 Congenital malformation of urinary system, unspecified	0.000	0.997	0.003
Q64.8 Other specified congenital malformations of urinary system	0.000	0.997	0.003
Q64.6 Congenital diverticulum of bladder	0.000	0.997	0.003
Q64.5 Congenital absence of bladder and urethra	0.000	0.997	0.003
Q64.2 Congenital posterior urethral valves	0.000	0.997	0.003
Q64.1 Exstrophy of urinary bladder	0.000	0.997	0.003
Q64.0 Epispadias	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
Q63.1 Lobulated, fused and horseshoe kidney	0.000	0.997	0.003
I08 Multiple valve diseases	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Q64.4 Malformation of urachus	0.000	0.997	0.003
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
I47 Paroxysmal tachycardia	0.003	0.997	0.000
Q55 Other congenital malformations of male genital organs	0.000	0.997	0.003
C92.9 Myeloid leukaemia, unspecified	0.003	0.997	0.000
Q61.0 Congenital single renal cyst	0.000	0.997	0.003
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.003	0.997	0.000
I47.9 Paroxysmal tachycardia, unspecified	0.003	0.997	0.000
Q62.8 Other congenital malformations of ureter	0.000	0.997	0.003
Q62.7 Congenital vesico-uretero-renal reflux	0.000	0.997	0.003
Q62.6 Malposition of ureter	0.000	0.997	0.003
Q62.4 Agenesis of ureter	0.000	0.997	0.003
Q62.2 Congenital megaloureter	0.000	0.997	0.003
Q62.1 Atresia and stenosis of ureter	0.000	0.997	0.003
Q62.0 Congenital hydronephrosis	0.000	0.997	0.003
Q54 Hypospadias	0.000	0.997	0.003
C86.5 Angioimmunoblastic T-cell lymphoma	0.003	0.997	0.000
Q55.6 Other congenital malformations of penis	0.000	0.997	0.003
C92.0 Acute myeloid leukaemia	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
Q52 Other congenital malformations of female genitalia	0.000	0.997	0.003
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.003	0.997	0.000
Q61 Cystic kidney disease	0.000	0.997	0.003
S51.0 Open wound of elbow	0.003	0.997	0.000
Q62.3 Other obstructive defects of renal pelvis and ureter	0.000	0.997	0.003
C90.2 Plasmacytoma, extramedullary	0.003	0.997	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
Q56 Indeterminate sex and pseudohermaphroditism	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.997	0.000
I08.9 Multiple valve disease, unspecified	0.003	0.997	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.003	0.997	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.003	0.997	0.000
C92.3 Myeloid sarcoma	0.003	0.997	0.000
C92.2 Subacute myeloid leukaemia	0.003	0.997	0.000
L89.2 Stage III decubitus ulcer	0.003	0.997	0.000
R25.8 Other and unspecified abnormal involuntary movements	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.997	0.000
D32 Benign neoplasm of meninges	0.000	0.997	0.003
S70.1 Contusion of thigh	0.003	0.997	0.000
C92.5 Acute myelomonocytic leukaemia	0.003	0.997	0.000
Q54.1 Hypospadias, penile	0.000	0.997	0.003
Q61.5 Medullary cystic kidney	0.000	0.997	0.003
Z12.8 Special screening examination for neoplasm of other sites	0.000	0.997	0.003
D32.0 Cerebral meninges	0.000	0.997	0.003
I47.0 Reentry ventricular arrhythmia	0.003	0.997	0.000
J02.9 Acute pharyngitis, unspecified	0.000	0.997	0.003
K46 Unspecified abdominal hernia	0.003	0.997	0.000
Q55.9 Congenital malformation of male genital organ, unspecified	0.000	0.997	0.002
Q55.8 Other specified congenital malformations of male genital organs	0.000	0.997	0.002
Q55.5 Congenital absence and aplasia of penis	0.000	0.997	0.002
Q55.3 Atresia of vas deferens	0.000	0.997	0.002
Q55.1 Hypoplasia of testis and scrotum	0.000	0.997	0.002
Q55.0 Absence and aplasia of testis	0.000	0.997	0.002
Q79.6 Ehlers-Danlos syndrome	0.000	0.997	0.003
C81 Hodgkin's disease	0.002	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.002
Q55.2 Other congenital malformations of testis and scrotum	0.000	0.997	0.002
T78.1 Other adverse food reactions, not elsewhere classified	0.003	0.997	0.000
Q52.1 Doubling of vagina	0.000	0.997	0.002
Q61.4 Renal dysplasia	0.000	0.997	0.002
Q55.4 Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate	0.000	0.997	0.002
Q54.9 Hypospadias, unspecified	0.000	0.997	0.002
Q51 Congenital malformations of uterus and cervix	0.000	0.997	0.002
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.002	0.997	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.000	0.997	0.003
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.000	0.998	0.002
I49.0 Ventricular fibrillation and flutter	0.002	0.998	0.000
Q54.8 Other hypospadias	0.000	0.998	0.002
Q54.4 Congenital chordee	0.000	0.998	0.002
Q54.3 Hypospadias, perineal	0.000	0.998	0.002
Q54.2 Hypospadias, penoscrotal	0.000	0.998	0.002
Q52.9 Congenital malformation of female genitalia, unspecified	0.000	0.998	0.002
Q52.8 Other specified congenital malformations of female genitalia	0.000	0.998	0.002
Q52.7 Other congenital malformations of vulva	0.000	0.998	0.002
Q52.6 Congenital malformation of clitoris	0.000	0.998	0.002
Q52.4 Other congenital malformations of vagina	0.000	0.998	0.002
Q52.3 Imperforate hymen	0.000	0.998	0.002
Q52.2 Congenital rectovaginal fistula	0.000	0.998	0.002
Q52.0 Congenital absence of vagina	0.000	0.998	0.002
Q74 Other congenital malformations of limb(s)	0.000	0.998	0.002
Q61.8 Other cystic kidney diseases	0.000	0.998	0.002
Q61.1 Polycystic kidney, infantile type	0.000	0.998	0.002
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
D32.1 Spinal meninges	0.000	0.998	0.002
Q52.5 Fusion of labia	0.000	0.998	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
C92.4 Acute promyelocytic leukaemia	0.002	0.998	0.000
T78.4 Allergy, unspecified	0.002	0.998	0.000
J46 Status asthmaticus	0.000	0.998	0.002
Q53 Undescended testicle	0.000	0.998	0.002
Q79 Congenital malformations of musculoskeletal system, not elsewhere classified	0.000	0.998	0.002
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
Q56.4 Indeterminate sex, unspecified	0.000	0.998	0.002
Q56.3 Pseudohermaphroditism, unspecified	0.000	0.998	0.002
Q56.2 Female pseudohermaphroditism, not elsewhere classified	0.000	0.998	0.002
Q56.1 Male pseudohermaphroditism, not elsewhere classified	0.000	0.998	0.002
Q56.0 Hermaphroditism, not elsewhere classified	0.000	0.998	0.002
Q74.1 Congenital malformation of knee	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
Z88.7 Personal history of allergy to serum and vaccine	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
K81.1 Chronic cholecystitis	0.000	0.998	0.002
Q00-Q07 Congenital malformations of the nervous system	0.000	0.998	0.002
L89.9 Decubitus ulcer and pressure area, unspecified	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
Q54.0 Hypospadias, balanic	0.000	0.998	0.002
Q76 Congenital malformations of spine and bony thorax	0.000	0.998	0.002
Q51.4 Unicornate uterus	0.000	0.998	0.002
J39.8 Other specified diseases of upper respiratory tract	0.000	0.998	0.002
K85.1 Biliary acute pancreatitis	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.000	0.998	0.002
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
N42.1 Congestion and haemorrhage of prostate	0.000	0.998	0.002
Q66 Congenital deformities of feet	0.000	0.998	0.002
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.000	0.998	0.002
E23.2 Diabetes insipidus	0.002	0.998	0.000
K46.1 Unspecified abdominal hernia with gangrene	0.002	0.998	0.000
Q74.2 Other congenital malformations of lower limb(s), including pelvic girdle	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
V49.9 Car occupant [any] injured in unspecified traffic accident	0.002	0.998	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.002	0.998	0.000
C81.3 Lymphocytic depletion	0.002	0.998	0.000
C81.0 Lymphocytic predominance	0.002	0.998	0.000
Q07.0 Arnold-Chiari syndrome	0.000	0.998	0.002
T42.1 Iminostilbenes	0.002	0.998	0.000
Q07 Other congenital malformations of nervous system	0.000	0.998	0.002
Q66.7 Pes cavus	0.000	0.998	0.002
Q76.1 Klippel-Feil syndrome	0.000	0.998	0.002
M25.59 Pain in joint (Site unspecified)	0.000	0.998	0.002
N80.8 Other endometriosis	0.000	0.998	0.002
Q51.9 Congenital malformation of uterus and cervix, unspecified	0.000	0.998	0.002
Q51.7 Congenital fistulae between uterus and digestive and urinary tracts	0.000	0.998	0.002
Q51.6 Embryonic cyst of cervix	0.000	0.998	0.002
Q51.5 Agenesis and aplasia of cervix	0.000	0.998	0.002
Q51.1 Doubling of uterus with doubling of cervix and vagina	0.000	0.998	0.002
Q51.0 Agenesis and aplasia of uterus	0.000	0.998	0.002
Q77 Osteochondrodysplasia with defects of growth of tubular bones and spine	0.000	0.998	0.002
Q75 Other congenital malformations of skull and face bones	0.000	0.998	0.002
Q73 Reduction defects of unspecified limb	0.000	0.998	0.002
Q72 Reduction defects of lower limb	0.000	0.998	0.002
Q71 Reduction defects of upper limb	0.000	0.998	0.002
Q70 Syndactyly	0.000	0.998	0.002
Q69 Polydactyly	0.000	0.998	0.002
Q66.2 Metatarsus varus	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
Q04 Other congenital malformations of brain	0.000	0.998	0.002
C81.2 Mixed cellularity	0.002	0.998	0.000
K46.0 Unspecified abdominal hernia with obstruction, without gangrene	0.002	0.998	0.000
Q74.9 Unspecified congenital malformation of limb(s)	0.000	0.998	0.002
Q74.8 Other specified congenital malformations of limb(s)	0.000	0.998	0.002
Q74.3 Arthrogryposis multiplex congenita	0.000	0.998	0.002
Q74.0 Other congenital malformations of upper limb(s), including shoulder girdle	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
Q68 Other congenital musculoskeletal deformities	0.000	0.998	0.002
Q98 Other sex chromosome abnormalities, male phenotype, not elsewhere classified	0.000	0.998	0.002
Q35-Q37 Cleft lip and cleft palate	0.000	0.998	0.002
C81.7 Other Hodgkin's disease	0.002	0.998	0.000
Q51.3 Bicornate uterus	0.000	0.998	0.002
Q61.9 Cystic kidney disease, unspecified	0.000	0.998	0.002
V27.4 Driver injured in traffic accident	0.000	0.998	0.002
G24.9 Dystonia, unspecified	0.002	0.998	0.000
Q53.9 Undescended testicle, unspecified	0.000	0.998	0.002
Q53.0 Ectopic testis	0.000	0.998	0.002
Q79.0 Congenital diaphragmatic hernia	0.000	0.998	0.002
Q27.3 Peripheral arteriovenous malformation	0.000	0.998	0.002
Q79.9 Congenital malformation of musculoskeletal system, unspecified	0.000	0.998	0.002
Q79.5 Other congenital malformations of abdominal wall	0.000	0.998	0.002
Q79.4 Prune belly syndrome	0.000	0.998	0.002
Q79.3 Gastroschisis	0.000	0.998	0.002
Q79.2 Exomphalos	0.000	0.998	0.002
Q30-Q34 Congenital malformations of the respiratory system	0.000	0.998	0.002
F02.3 Dementia in Parkinson's disease	0.000	0.998	0.002
T78 Adverse effects, not elsewhere classified	0.002	0.998	0.000
Q66.0 Talipes equinovarus	0.000	0.998	0.002
Q76.4 Other congenital malformations of spine, not associated with scoliosis	0.000	0.998	0.002
Q98.4 Klinefelter's syndrome, unspecified	0.000	0.998	0.002
F02.8 Dementia in other specified diseases classified elsewhere	0.000	0.998	0.002
Q51.2 Other doubling of uterus	0.000	0.998	0.002
Q66.3 Other congenital varus deformities of feet	0.000	0.998	0.002
Q76.0 Spina bifida occulta	0.000	0.998	0.002
Q06 Other congenital malformations of spinal cord	0.000	0.998	0.002
Q03 Congenital hydrocephalus	0.000	0.998	0.002
Q01 Encephalocele	0.000	0.998	0.002
Q00 Anencephaly and similar malformations	0.000	0.998	0.002
Q02 Microcephaly	0.000	0.998	0.002
I95.0 Idiopathic hypotension	0.002	0.998	0.000
Q67 Congenital musculoskeletal deformities of head, face, spine and chest	0.000	0.998	0.002
Q96 Turner's syndrome	0.000	0.998	0.002
Q04.6 Congenital cerebral cysts	0.000	0.998	0.002
Q76.9 Congenital malformation of bony thorax, unspecified	0.000	0.998	0.002
Q76.8 Other congenital malformations of bony thorax	0.000	0.998	0.002
Q76.7 Congenital malformation of sternum	0.000	0.998	0.002
Q76.6 Other congenital malformations of ribs	0.000	0.998	0.002
Q76.3 Congenital scoliosis due to congenital bony malformation	0.000	0.998	0.002
Q76.2 Congenital spondylolisthesis	0.000	0.998	0.002
T42.3 Barbiturates	0.002	0.998	0.000
D52.9 Folate deficiency anaemia, unspecified	0.000	0.998	0.002
N75.0 Cyst of Bartholin's gland	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
Q97 Other sex chromosome abnormalities, female phenotype, not elsewhere classified	0.000	0.998	0.002
Q95 Balanced rearrangements and structural markers, not elsewhere classified	0.000	0.998	0.002
Q93 Monosomies and deletions from the autosomes, not elsewhere classified	0.000	0.998	0.002
Q92 Other trisomies and partial trisomies of the autosomes, not elsewhere classified	0.000	0.998	0.002
Q91 Edwards' syndrome and Patau's syndrome	0.000	0.998	0.002
Q66.6 Other congenital valgus deformities of feet	0.000	0.998	0.002
Q66.5 Congenital pes planus	0.000	0.998	0.002
Q66.4 Talipes calcaneovalgus	0.000	0.998	0.002
Q66.1 Talipes calcaneovarus	0.000	0.998	0.002
T42.0 Hydantoin derivatives	0.002	0.998	0.000
Q90 Down's syndrome	0.000	0.998	0.002
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
Q79.1 Other congenital malformations of diaphragm	0.000	0.998	0.002
T45.5 Anticoagulants	0.001	0.998	0.001
T78.2 Anaphylactic shock, unspecified	0.002	0.998	0.000
Q07.9 Congenital malformation of nervous system, unspecified	0.000	0.998	0.002
Q79.8 Other congenital malformations of musculoskeletal system	0.000	0.998	0.002
Q78 Other osteochondrodysplasias	0.000	0.998	0.002
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.000	0.998	0.002
K11.5 Sialolithiasis	0.000	0.998	0.002
K76.6 Portal hypertension	0.002	0.998	0.000
Q65 Congenital deformities of hip	0.000	0.998	0.002
Q53.2 Undescended testicle, bilateral	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations